Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PPP3CB antisense RNA 1 (PPP3CB-AS1) is a non-coding RNA gene, classified as a long non-coding RNA (lncRNA), which is transcribed antisense to the PPP3CB coding gene[2][4][6]. There are currently no functional transcripts or characterized protein products associated with PPP3CB-AS1, and its biological function, involvement in disease, or use as a therapeutic target or biomarker has not been established. PPP3CB-AS1 is not considered a therapeutic target such as a receptor, enzyme, transporter, or signaling protein. No drugs or mechanisms of action are described for this RNA, and it is not associated with clinical safety concerns.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PPP3CB antisense RNA 1 (PPP3CB-AS1).